SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Gyrodyne, LLC – ‘10-Q’ for 3/31/21 – ‘EX-31.1’

On:  Friday, 5/7/21, at 12:09pm ET   ·   For:  3/31/21   ·   Accession #:  1437749-21-11258   ·   File #:  1-37547

Previous ‘10-Q’:  ‘10-Q’ on 11/13/20 for 9/30/20   ·   Next:  ‘10-Q’ on 8/6/21 for 6/30/21   ·   Latest:  ‘10-Q’ on 11/14/23 for 9/30/23   ·   5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/07/21  Gyrodyne, LLC                     10-Q        3/31/21   57:2.8M                                   RDG Filings/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    292K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     20K 
 3: EX-32.1     Certification -- §906 - SOA'02                      HTML     18K 
10: R1          Document And Entity Information                     HTML     49K 
11: R2          Consolidated Statements of Net Assets (Liquidation  HTML     60K 
                Basis) (Current Period Unaudited)                                
12: R3          Consolidated Statement of Changes in Net Assets     HTML     25K 
                (Liquidation Basis) (Unaudited)                                  
13: R4          Note 1 - The Company                                HTML     27K 
14: R5          Note 2 - Basis of Quarterly Presentations           HTML     21K 
15: R6          Note 3 - Summary of Significant Accounting          HTML     31K 
                Policies                                                         
16: R7          Note 4 - Statements of Net Assets in Liquidation    HTML     34K 
17: R8          Note 5 - Estimated Liquidation and Operating Costs  HTML     49K 
                Net of Estimated Receipts                                        
18: R9          Note 6 - Disposition Activities                     HTML     26K 
19: R10         Note 7 - Loans Payable                              HTML     40K 
20: R11         Note 8 - Accounts Payable and Accrued Liabilities   HTML     38K 
21: R12         Note 9 - Income Taxes                               HTML     24K 
22: R13         Note 10 - Credit Quality of Rents Receivable        HTML     21K 
23: R14         Note 11 - Concentration of Credit Risk              HTML     24K 
24: R15         Note 12 - Commitments                               HTML     43K 
25: R16         Note 13 - Contingencies                             HTML     22K 
26: R17         Note 14 - Fair Value of Financial Instruments       HTML     27K 
27: R18         Note 15 - COVID-19                                  HTML     27K 
28: R19         Note 16 - Related Party Transactions                HTML     36K 
29: R20         Note 17 - Subsequent Events                         HTML     20K 
30: R21         Significant Accounting Policies (Policies)          HTML     49K 
31: R22         Note 5 - Estimated Liquidation and Operating Costs  HTML     45K 
                Net of Estimated Receipts (Tables)                               
32: R23         Note 7 - Loans Payable (Tables)                     HTML     26K 
33: R24         Note 8 - Accounts Payable and Accrued Liabilities   HTML     36K 
                (Tables)                                                         
34: R25         Note 12 - Commitments (Tables)                      HTML     31K 
35: R26         Note 16 - Related Party Transactions (Tables)       HTML     30K 
36: R27         Note 1 - The Company (Details Textual)              HTML     32K 
37: R28         Note 3 - Summary of Significant Accounting          HTML     18K 
                Policies (Details Textual)                                       
38: R29         Note 4 - Statements of Net Assets in Liquidation    HTML     48K 
                (Details Textual)                                                
39: R30         Note 5 - Estimated Liquidation and Operating Costs  HTML     20K 
                Net of Estimated Receipts (Details Textual)                      
40: R31         Note 5 - Estimated Liquidation and Operating Costs  HTML     74K 
                Net of Estimated Receipts - Changes in Liability                 
                for Estimated Costs in Excess of Estimated                       
                Receipts (Details)                                               
41: R32         Note 6 - Disposition Activities (Details Textual)   HTML     24K 
42: R33         Note 7 - Loans Payable (Details Textual)            HTML     79K 
43: R34         Note 7 - Loan Payable - Loan Maturity (Details)     HTML     32K 
44: R35         Note 8 - Accounts Payable and Accrued Liabilities   HTML     17K 
                (Details Textual)                                                
45: R36         Note 8 - Accounts Payable and Accrued Liabilities   HTML     31K 
                - Accounts Payable and Accrued Liabilities                       
                (Details)                                                        
46: R37         Note 9 - Income Taxes (Details Textual)             HTML     17K 
47: R38         Note 11 - Concentration of Credit Risk (Details     HTML     32K 
                Textual)                                                         
48: R39         Note 12 - Commitments (Details Textual)             HTML     46K 
49: R40         Note 12 - Commitments - Other Commitments           HTML     21K 
                (Details)                                                        
50: R41         Note 12 - Commitments - Allocation of Retention     HTML     26K 
                Bonus (Details)                                                  
51: R42         Note 15 - COVID-19 (Details Textual)                HTML     26K 
52: R43         Note 16 - Related Party Transactions (Details       HTML     30K 
                Textual)                                                         
53: R44         Note 16 - Related Party Transactions - Summary of   HTML     30K 
                Leasing Arrangements (Details)                                   
54: R45         Note 17 - Subsequent Events (Details Textual)       HTML     21K 
56: XML         IDEA XML File -- Filing Summary                      XML    104K 
55: EXCEL       IDEA Workbook of Financial Reports                  XLSX     52K 
 4: EX-101.INS  XBRL Instance -- gyro-20210331                       XML    632K 
 6: EX-101.CAL  XBRL Calculations -- gyro-20210331_cal               XML     45K 
 7: EX-101.DEF  XBRL Definitions -- gyro-20210331_def                XML    804K 
 8: EX-101.LAB  XBRL Labels -- gyro-20210331_lab                     XML    553K 
 9: EX-101.PRE  XBRL Presentations -- gyro-20210331_pre              XML    812K 
 5: EX-101.SCH  XBRL Schema -- gyro-20210331                         XSD    154K 
57: ZIP         XBRL Zipped Folder -- 0001437749-21-011258-xbrl      Zip     90K 


‘EX-31.1’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <>  <>  C:  <> 

 

Exhibit 31.1

 

Rule 13a-14(a)/15d-14(a) Certification

 

I, Gary Fitlin, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Gyrodyne, LLC;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

 

 

Date: May 7, 2021  
   
 

/s/ Gary Fitlin

By Gary Fitlin,

President and Chief Executive Officer,

Chief Financial Officer and Treasurer

                                                                                                                                                                            

 

 

 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:5/7/21
For Period end:3/31/21NT 10-K
 List all Filings 


5 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/02/18  Gyrodyne, LLC                     8-K:1,9    10/30/18    2:46K                                    RDG Filings/FA
 1/31/18  Gyrodyne, LLC                     8-K:1,9     1/25/18    3:159K                                   RDG Filings/FA
 5/26/16  Gyrodyne, LLC                     8-K:1,8,9   5/24/16    3:146K                                   RDG Filings/FA
 9/01/15  Gyrodyne, LLC                     8-A12B                 2:396K                                   RDG Filings/FA
10/21/13  Gyrodyne, LLC                     S-4        10/18/13    6:6M                                     Toppan Vite NY Inc./FA
Top
Filing Submission 0001437749-21-011258   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 6:42:31.1pm ET